TELA Bio
TELA
45 hedge funds and large institutions have $117M invested in TELA Bio in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 4 closing their positions.
325% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 4
63% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 8
59% more capital invested
Capital invested by funds: $73.8M → $117M (+$43.4M)
41% more funds holding
Funds holding: 32 → 45 (+13)
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
5.34% less ownership
Funds ownership: 92.96% → 87.61% (-5.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$10.1M |
| 2 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$5.82M |
| 3 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
+$4.52M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$3.26M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$2.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$5.2M |
| 2 |
IV
Industry Ventures
San Francisco,
California
|
-$4.06M |
| 3 |
HLA
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
|
-$1.85M |
| 4 |
JG
Jefferies Group
New York
|
-$1.02M |
| 5 |
PVI
Pura Vida Investments
New York
|
-$295K |
TELA Hedge Fund Activity: Q3 2022 in Review
45 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q3 2022, worth a combined $117M — up 59% from $73.8M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new TELA positions and 4 closed out — a net gain of 13 holders — while 13 added to existing stakes and 8 trimmed.
The largest buyer was AIGH Capital Management, adding an estimated $10.1M. The largest seller was RTW Investments, cutting an estimated $5.2M.
- 45 institutional investors held TELA Bio (TELA) as of Q3 2022, up from 32 in Q2 2022.
- Funds reported $117M of TELA Bio stock for Q3 2022, up 59% quarter-over-quarter.
- 17 funds opened new TELA Bio positions in Q3 2022 and 4 closed out, a net change of +13 holders.
- The largest TELA Bio buyer in Q3 2022 was AIGH Capital Management, an estimated $10.1M added.
- The largest TELA Bio seller in Q3 2022 was RTW Investments, an estimated $5.2M sold.
Based on aggregated 13F filings for Q3 2022.